Penumbra, Inc. is a global healthcare company that stands out for its commitment to addressing unmet medical needs through the design, development, and marketing of novel products, such as the Penumbra System for the treatment of acute ischemic stroke. The company's culture fosters continuous learning and growth, with a strong emphasis on the value of every team member's ideas. Recognized as one of the fastest-growing companies by Fortune in 2019, Penumbra's industry leadership is evident in its direct sales organization that serves major markets including the United States, Europe, Canada, and Australia.